Laporan Laba Rugi 1720 - TTM - Standard Chemical & Pharmaceutical Co. Ltd.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Standard Chemical & Pharmaceutical Co. Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	4,219	4,305	4,372	4,413	4,489	4,604	4,740	5,072	5,501	5,851	6,107	6,135	6,231	6,240	6,360	6,611	6,708	6,789	6,816	6,884
Change (%)		2.05	1.55	0.94	1.71	2.57	2.96	7.00	8.46	6.37	4.37	0.46	1.56	0.14	1.93	3.95	1.47	1.21	0.39	0.99
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	2,349	2,386	2,411	2,437	2,456	2,536	2,649	2,857	3,154	3,364	3,457	3,472	3,514	3,514	3,601	3,712	3,769	3,801	3,842	3,964
Change (%)		1.56	1.08	1.07	0.78	3.26	4.43	7.88	10.38	6.65	2.76	0.45	1.19	0.02	2.47	3.07	1.55	0.83	1.10	3.17
% of Revenue	55.67	55.41	55.16	55.23	54.72	55.09	55.88	56.33	57.33	57.49	56.60	56.60	56.39	56.32	56.62	56.14	56.19	55.98	56.37	57.58

Gross Operating Profit	1,870	1,920	1,961	1,976	2,032	2,068	2,092	2,215	2,347	2,488	2,651	2,663	2,717	2,725	2,759	2,900	2,939	2,989	2,974	2,920
Change (%)		2.65	2.13	0.77	2.86	1.75	1.15	5.89	5.98	5.98	6.55	0.46	2.04	0.31	1.24	5.10	1.35	1.69	-0.51	-1.81
% of Revenue	44.33	44.59	44.84	44.77	45.28	44.91	44.12	43.67	42.67	42.51	43.40	43.40	43.61	43.68	43.38	43.86	43.81	44.02	43.63	42.42

SG&A	962	986	973	983	980	949	970	988	1,034	1,117	1,151	1,174	1,209	1,200	1,225	1,272	1,287	1,304	1,312	1,302
Change (%)		2.51	-1.35	1.04	-0.26	-3.17	2.21	1.84	4.65	8.08	3.04	1.97	3.00	-0.81	2.09	3.85	1.21	1.31	0.59	-0.75
% of Revenue	22.80	22.90	22.25	22.27	21.84	20.62	20.47	19.48	18.79	19.10	18.85	19.14	19.41	19.22	19.25	19.24	19.19	19.21	19.25	18.91

R&D	220	227	233	239	237	242	243	249	256	252	250	246	252	266	270	286	284	288	289	273
Change (%)		3.08	2.40	2.82	-1.05	2.15	0.47	2.41	2.88	-1.59	-0.74	-1.58	2.21	5.87	1.52	5.98	-0.85	1.42	0.38	-5.49
% of Revenue	5.22	5.28	5.32	5.42	5.27	5.25	5.12	4.91	4.65	4.30	4.09	4.01	4.04	4.27	4.25	4.33	4.23	4.24	4.24	3.97

OpEx	3,531	3,599	3,617	3,659	3,673	3,727	3,862	4,094	4,444	4,733	4,858	4,893	4,975	4,980	5,096	5,270	5,340	5,393	5,443	5,539
Change (%)		1.92	0.50	1.18	0.38	1.47	3.61	6.02	8.54	6.51	2.64	0.71	1.68	0.11	2.32	3.41	1.34	0.98	0.94	1.76
% of Revenue	83.69	83.59	82.72	82.92	81.84	80.96	81.47	80.72	80.78	80.89	79.55	79.75	79.84	79.81	80.12	79.71	79.61	79.43	79.86	80.47

Operating Income	688	707	755	754	815	877	878	978	1,057	1,118	1,249	1,243	1,256	1,260	1,264	1,342	1,368	1,397	1,373	1,345
Change (%)		2.72	6.89	-0.20	8.17	7.54	0.18	11.34	8.12	5.76	11.69	-0.52	1.09	0.27	0.37	6.12	1.96	2.09	-1.71	-2.04
% of Revenue	16.31	16.41	17.28	17.08	18.16	19.04	18.53	19.28	19.22	19.11	20.45	20.25	20.16	20.19	19.88	20.29	20.39	20.57	20.14	19.53

Interest Expense	-9	-8	-7	-7	-7	-7	-9	-10	-13	-19	-21	-26	-27	-25	-25	-21	-19	-15	-11	-9
Change (%)		-12.62	-6.06	0.42	-3.33	5.00	17.89	17.67	28.04	45.80	13.35	21.50	4.72	-6.13	-1.66	-14.00	-11.51	-20.79	-23.80	-19.73
% of Revenue	-0.21	-0.18	-0.16	-0.16	-0.15	-0.16	-0.18	-0.20	-0.23	-0.32	-0.35	-0.42	-0.43	-0.41	-0.39	-0.33	-0.28	-0.22	-0.17	-0.13

Net Income	461	524	612	649	694	707	672	734	813	815	853	863	848	835	877	854	848	881	822	803
Change (%)		13.60	16.83	5.94	6.95	1.85	-4.95	9.28	10.81	0.24	4.61	1.15	-1.71	-1.56	5.00	-2.57	-0.76	3.88	-6.59	-2.38
% of Revenue	10.94	12.17	14.01	14.70	15.46	15.35	14.17	14.47	14.79	13.94	13.97	14.06	13.61	13.38	13.78	12.92	12.63	12.97	12.07	11.66

Source: Capital IQ

Standard Chemical & Pharmaceutical Co. Ltd. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)